A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)

BACKGROUND: The clinical and economic burden of community-acquired bacterial pneumonia (CABP) is significant and is anticipated to increase as the population ages and pathogens become more resistant. Delafloxacin is a fluoroquinolone antibiotic approved in the United States for the treatment of adul...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Horcajada, Juan P, Salata, Robert A, Álvarez-Sala, Rodolfo, Nitu, Floarea Mimi, Lawrence, Laura, Quintas, Megan, Cheng, Chun-Yen, Cammarata, Sue
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Major Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6975251/
https://ncbi.nlm.nih.gov/pubmed/31988972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz514
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars